AzTrials
AzTrials

Respiratory FailureCYCLOPESNCT05952726

Inspiratory Effort at Different Expiratory Cycling and Airway Resistance During Pressure Support Ventilation (CYCLOPES)

A study testing Expiratory cycling change at different levels of pressure support ventilation in people with Respiratory Failure, run by Fondazione IRCCS San Gerardo dei Tintori at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this prospective interventional crossover randomized physiological study is to investigate the reliability of Pressure Muscle Index (PMI) - as an estimation of inspiratory effort - at different levels of expiratory cycling during pressure support ventilation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Respiratory Failure
What is being tested?
Expiratory cycling change at different levels of pressure support ventilation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteItaly
Study dates
1 Aug 2023to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Invasive mechanical ventilation in PSV
  • Presence of spontaneous breathing activity (ventilator triggering), since 6 hours and no longer than 72 hours after
  • Weaning from mechanical ventilation
  • Patient for full active management
  • Subject ≥ 18 years
  • Informed consent

Who cannot join

  • Age <18 years old
  • Pregnancy
  • Active air leaks
  • Chronic Obstructive Pulmonary Disease and/or asthma
  • Moribund state
  • Neurological conditions potentially impairing the ventilatory drive (e.g. meningitis, encephalitis) and neuromuscular diseases impairing neuromuscular conduction (e.g. Guillain-Barre syndrome)
  • Extracorporeal membrane oxygenation (ECMO)

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Fondazione IRCCS San Gerardo dei Tintori

    Monza, MB, 20900

Other trials in Italy

About this study

Official title: Inspiratory Effort and Airway Resistance Assessment During Assisted Mechanical Ventilation in Critically Ill Patients at Different Levels of Expiratory Cycling: a Cross-over Randomized Physiological Study (CYCLOPES)

The goal of this prospective interventional crossover randomized physiological study is to investigate the reliability of Pressure Muscle Index (PMI) - as an estimation of inspiratory effort - at different levels of expiratory cycling during pressure support ventilation. PMI will be compared with the esophageal pressure swing that is considered the gold standard technique.

This study aims to answer to the following questions:

  • which is the optimal expiratory cycling threshold where PMI better correlates with the esophageal pressure swing?
  • what is the optimal correlation between the occlusion pressure (Poc) estimated by an expiratory occlusion manoeuvre and P0.1 with PMI obtained at various degrees of expiratory cycling threshold?
  • does airway resistance - evaluated by using esophageal pressure - correlate with the estimation of airway resistance on the pressure-time waveform by a high percentage of expiratory cycling mimicking the interrupter technique?
Read the detailed description

The concept of Patient-Self-Inflicted Lung Injury (P-SILI) defines the injury that a patient may cause to the lungs while exerting strong inspiratory efforts. During assisted spontaneous breathing, the alveolar distending pressure results from both the positive pressure delivered by the ventilator and the negative pressure generated by the patient. If the patient generates very low negative pleural pressure (Ppl), this may result in an elevated alveolar distending pressure (i.e. transpulmonary pressure). The assessment of esophageal pressure (Pes) - as a surrogate of Ppl - allows to estimate the transpulmonary pressure. However, oesophageal pressure monitoring is not commonly used across different Institutions and it is not often the standard of care to estimate the inspiratory effort and transpulmonary pressure. A manual inspiratory hold is a bedside available tool to potentially estimate a safe threshold of airway pressure, as it can reliably estimate plateau pressure (Pplat) during assisted mechanical ventilation and driving pressure (DP). The difference between peak (Ppeak) and plateau pressure (Pplat) during pressure support ventilation results in the pressure muscle index (PMI) which is considered a reliable measurement of the elastic contribution of patient's inspiratory effort. This index is a simple bedside tool able to uncover the "hidden pressure" that the patient generates during pressure support ventilation and it tightly correlates with the muscular pressure at end inspiration measured by a Pes catheter. Nowadays, in most ventilators, percentage of the peak flow can be adjusted from as low as 1% to as high as 80% resulting in longer or shorter inspiratory times, respectively. Therefore, Pplat can be equal or lower that Ppeak in the absence of inspiratory effort. In the presence of an inspiratory effort, after a manual inspiratory hold, the pressure generated by the patient will be released and the level of Pplat may be visible above Ppeak to an extent that may change based on the set expiratory cycling. We therefore aim to verifying whether pressure muscle index (PMI) - obtained by the pressure time waveform on the ventilator and used as an estimation of the inspiratory effort - is differently correlated with esophageal pressure swing (i.e. gold standard to describe the inspiratory effort) by changing expiratory cycling at different levels of pressure support. Furthermore, inspiratory effort estimated by PMI at different levels of pressure support and expiratory cycling will be compared with another estimator of patient's effort, the Pocc. Pocc is the pressure under assisted ventilation when the airway is briefly occluded during an expiratory manoeuvre. As last, during the steps at an early expiratory cycling (60%), the pressure-time waveform will be evaluated and airway resistance will be estimated by mimicking the interrupter technique. This will be compared to the estimation of the airway resistive component by using the esophageal catheter. Patients will be enrolled at least 6 hours after and within 72 hours since the switch to PSV from controlled mechanical ventilation modalities (CMV).

At this time, the following parameters will be recorded:

  • Patient demographics (including age, gender, height, weight, predicted body weight)
  • Date/time of informed consent
  • Date and time of hospital and ICU admission
  • Comorbidities
  • Smoking history and status
  • Admission diagnoses
  • Date/time of onset of mechanical ventilation
  • Determinants of Sequential Organ Failure Assessment (SOFA) score at ICU admission
  • Ventilation parameters, level of sedation (RASS scale), sedative drugs and arterial blood gas analysis on the day before the switch to PSV and at the study enrolment
  • Prior use of adjunctive therapies including neuromuscular blocking agents (NMBA) and prone position
  • Components of the SOFA score at the enrolment. Esophageal pressure will be measured by using a specific nasogastic feeding tube with an air-filled balloon. Three levels of pressure support will be explored randomly: a clinical pressure support, and 4 cmH2O of PS above and below the clinical pressure support At each level of pressure support, four sets of data will be recorded by randomly varying the expiratory cycling threshold: 15%, 30%, 45% and 60 % of peak inspiratory flow. After switching from one level of expiratory cycling to the new one, a ten minutes interval will be required before the data collection, in order to allow the patient to adapt to the new ventilation setting.

For each degree of expiratory cycling, the following parameters will be recorded:

  • Ventilation parameters: PEEP, PS, Inspiratory and expiratory trigger, Inspiratory rising time
  • Ventilatory mechanics measurements (3 times each): RR, TV, Ppeak, Pplat, total PEEP, P0.1, occlusion pressure (Poc), end-inspiratory Pes and end-expiratory Pes after and inspiratory and expiratory occlusion maneuvers of 3 seconds, respectively
  • Esophageal pressure swings evaluation - 20 breaths for each level of pressure support ventilation and each level of expiratory cycling at steady state considered at the end of the 10 minute step.

In addition, the following parameters will be reported:

  • Maximal Inspiratory Pressure (MIP) and Pes during MIP (one single measurement)
  • Level of sedation (RASS scale) and type of sedative drugs
  • Arterial blood gas analysis
  • Determinants of SOFA Score. Patients will be followed up until ICU and hospital discharge. Data regarding ICU and hospital mortality will be collected, as well as total duration of mechanical ventilation, total duration of CMV and PSV.
Being tested
Expiratory cycling change at different levels of pressure support ventilation
Keywords
pressure support, esophageal pressure, pressure muscle index, expiratory cycling, inspiratory effort, plateau pressure, transpulmonary pressure, airway resistance, occlusion pressure
Medical subject headings
Respiratory Insufficiency

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Expiratory cycling change at different levels of pressure support ventilationOther

    Four different levels of expiratory cycling will be randomly applied at 3 different degrees of pressure support.

    Three end-inspiratory and three end-expiratory occlusion manoeuvres will be carried out at the end of 10 minute steps of ventilation during each set value expiratory cycling and pressure support level.

    Total study time will be about 120 minutes. Levels of pressure support wil be clinical pressure support ± 4 cmH2O; expiratory cycling percentages applied for each pressure support step will be 15%, 30%, 45% and 60% of peak inspiratory flow.

Study groups in NCT05952726
Study groupRoleWhat they receive
Prolonged expiratory cyclingExperimental15% expiratory cycling during pressure support ventilation
Receives: Other: Expiratory cycling change at different levels of pressure support ventilation
Late expiratory cyclingExperimental30% expiratory cycling during pressure support ventilation
Receives: Other: Expiratory cycling change at different levels of pressure support ventilation
Medium expiratory cyclingExperimental45% expiratory cycling during pressure support ventilation
Receives: Other: Expiratory cycling change at different levels of pressure support ventilation
Early expiratory cyclingExperimental60% expiratory cycling during pressure support ventilation
Receives: Other: Expiratory cycling change at different levels of pressure support ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure muscle index (PMI) as a bedside estimation of inspiratory effort at different expiratory cycling levels during different levels of pressure support.

    To verify whether pressure muscle index (PMI) - obtained by the pressure time waveform on the ventilator and used as an estimation of the inspiratory effort - is differently correlated with esophageal pressure swing (i.e. gold standard to describe the inspiratory effort) by changing expiratory cycling, over different levels of pressure support ventilation.

    Measured: After at least 6 hours after and within 72 hours since switch from controlled ventilation to pressure support ventilation.

Secondary outcomes (3)
  1. Correlation between PMI and other measures of inspiratory effort (Pocc) and inspiratory drive (P0.1).

    To evaluate the correlation between different measures of inspiratory effort (i.e. Pocc) and inspiratory drive (i.e. P0.1) with PMI obtained at various degree of expiratory cycling and different levels of pressure support.

    Measured: After at least 6 hours after and within 72 hours since switch from controlled ventilation to pressure support ventilation

  2. Airway resistances during assisted mechanical ventilation.

    To evaluate if airways resistance, evaluated by esophageal pressure, correlates with the estimation of airway resistance on the pressure-time waveform by a high percentage of expiratory cycling mimicking the interrupter technique.

    Measured: After at least 6 hours after and within 72 hours since switch from controlled ventilation to pressure support ventilation

  3. Tidal volume variability

    To evaluate tidal variability across different levels of pressure support ventilation and different levels of expiratory cycling and investigate how tidal variability different correlates with the inspiratory effort by using deltaPes, PMI and Pocc.

    Measured: After at least 6 hours after and within 72 hours since switch from controlled ventilation to pressure support ventilation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2023
  2. Study start1 Aug 2023
  3. Primary completion1 Feb 2025
  4. Study completion1 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Model description
Crossover randomisation of different levels of expiratory cycling during randomised levels of pressure support ventilation in critically ill patients undergoing assisted mechanical ventilation.
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05952726
Sponsor's protocol ID
CYCLOPES
Acronym
CYCLOPES
Status last verified
May 2025
First submitted
4 Jul 2023
Last updated
19 Sep 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Foti G, Cereda M, Banfi G, Pelosi P, Fumagalli R, Pesenti A. End-inspiratory airway occlusion: a method to assess the pressure developed by inspiratory muscles in patients with acute lung injury undergoing pressure support. Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1210-6. doi: 10.1164/ajrccm.156.4.96-02031.

    PubMed 9351624
  • Bellani G, Grassi A, Sosio S, Gatti S, Kavanagh BP, Pesenti A, Foti G. Driving Pressure Is Associated with Outcome during Assisted Ventilation in Acute Respiratory Distress Syndrome. Anesthesiology. 2019 Sep;131(3):594-604. doi: 10.1097/ALN.0000000000002846.

    PubMed 31335543
  • Teggia-Droghi M, Grassi A, Rezoagli E, Pozzi M, Foti G, Patroniti N, Bellani G. Comparison of Two Approaches to Estimate Driving Pressure during Assisted Ventilation. Am J Respir Crit Care Med. 2020 Dec 1;202(11):1595-1598. doi: 10.1164/rccm.202004-1281LE. No abstract available.

    PubMed 32678669
  • Bertoni M, Telias I, Urner M, Long M, Del Sorbo L, Fan E, Sinderby C, Beck J, Liu L, Qiu H, Wong J, Slutsky AS, Ferguson ND, Brochard LJ, Goligher EC. A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care. 2019 Nov 6;23(1):346. doi: 10.1186/s13054-019-2617-0.

    PubMed 31694692
  • Bianchi I, Grassi A, Pham T, Telias I, Teggia Droghi M, Vieira F, Jonkman A, Brochard L, Bellani G. Reliability of plateau pressure during patient-triggered assisted ventilation. Analysis of a multicentre database. J Crit Care. 2022 Apr;68:96-103. doi: 10.1016/j.jcrc.2021.12.002. Epub 2021 Dec 21.

    PubMed 34952477
  • Pesenti A, Pelosi P, Foti G, D'Andrea L, Rossi N. An interrupter technique for measuring respiratory mechanics and the pressure generated by respiratory muscles during partial ventilatory support. Chest. 1992 Sep;102(3):918-23. doi: 10.1378/chest.102.3.918.

    PubMed 1516422

Questions about this trial

What is this clinical trial studying?

A study testing Expiratory cycling change at different levels of pressure support ventilation in people with Respiratory Failure, run by Fondazione IRCCS San Gerardo dei Tintori at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure muscle index (PMI) as a bedside estimation of inspiratory effort at different expiratory cycling levels during different levels of pressure support. (time frame: After at least 6 hours after and within 72 hours since switch from controlled ventilation to pressure support ventilation.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05952726, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2025; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in